SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
Q特别忠茶
Lv3
1
220 积分
2022-09-13 加入
最近求助
最近应助
互助留言
Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer
2小时前
已完结
Effects of interventions for enhancing resilience in cancer patients: A systematic review and network meta-analysis
2个月前
已完结
Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis
2个月前
已完结
Interventions for Glaucoma Medication Adherence Improvement
2个月前
已完结
Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells
3个月前
已完结
VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
4个月前
已关闭
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer
4个月前
已完结
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
4个月前
已完结
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
4个月前
已完结
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer
4个月前
已完结
没有进行任何应助
标题错误
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论